The GNAL gene helps brain cells pass along dopamine related signals that support smooth, controlled movement. This gene plays an important role in communication pathways used by movement centers in the brain and by smell sensing cells in the nose. When the GNAL gene does not work properly, some people develop an inherited form of dystonia, with involuntary muscle contractions, unusual postures, or voice and neck symptoms that often start in adulthood. GNAL is mainly known in neurology rather than popular culture.
What is a gene?
Genes are sections of DNA that carry instructions your cells use to make molecules or direct processes in the body. Some genes hold the instructions for producing proteins, the parts of cells that do much of the work. Others mostly help regulate when certain processes happen, where they happen, and how active they are. Taken together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. For a deeper look at this topic, you can read more in the LearnHub.
Overview
GNALGene function
What if the gene works
The GNAL gene helps brain cells and cells involved in smell pass signals. Its protein is part of a switch that carries messages from certain receptors, including dopamine pathways involved in smooth, controlled movement.
Risk
What if the gene does not work
Variants in the GNAL gene are linked to adult-onset dystonia, usually affecting the neck, face, jaw, or voice. Milder and more severe variants can influence which muscles are involved and how noticeable symptoms become.
Treatment
What does that mean for your treatment
No treatment or drug choice is currently guided specifically by a pathogenic variant in the GNAL gene; care is based on symptoms rather than the GNAL variant itself.
Conditions associated with GNAL
Gene function
What if the gene works
Your cells use the GNAL gene to pass along specific messages from the cell surface to the inside of the cell. This is especially important in smell receptor cells and in some brain cells that help coordinate movement. Its protein acts like a switch that helps start a signaling chain after a receptor detects a cue.
The GNAL gene makes part of a signaling switch that carries messages from certain surface receptors into the cell. This helps cells respond to outside cues in an organized way.
After a receptor is activated, the GNAL protein can help turn on adenylyl cyclase, an enzyme that makes cAMP (a common signal messenger). This messenger helps pass the signal onward inside the cell.
In smell receptor cells in the nose, GNAL helps turn odor detection into a signal the brain can interpret. This is a key part of how the GNAL gene helps with smell signaling, from noticing food aromas to recognizing smoke.
In certain brain cells, GNAL helps pass along signals from receptors involved in movement control. This supports smooth communication in pathways that guide everyday motion.
What is a variant?
A genetic variant is a minor change in the DNA sequence within a gene. These changes are common and help explain normal differences among people, such as appearance, metabolism, or the way the body responds to environmental influences. Many variants do not have any noticeable effect and are simply part of natural genetic variation. Sometimes, however, a variant can more significantly change how a gene works and may contribute to or lead to a genetic condition.
Genetic variants
What if the gene does not work
Variants in the GNAL gene can change the GNAL protein's shape, stability, or ability to pass signals from dopamine receptors inside nerve cells. In studies of how GNAL gene variants affect protein function, some changes only partly reduce this signaling, while more disruptive variants can sharply lower it or stop it. This loss of function may weaken brain pathways involved in movement, and in some families a larger drop in activity is linked to earlier or more marked dystonia.
How variants are linked to conditions
Pathogenic variants in the GNAL gene cause a rare inherited form of dystonia, often called GNAL-related dystonia. In studies of GNAL gene variants linked to dystonia, symptoms usually begin in adulthood and often affect the neck first, though the face, jaw, or voice can also be involved. Some people develop more widespread movement symptoms, but the pattern and severity can vary from one person to another.
A variant is not necessarily a diagnosis
Variants in genes are a normal feature of human biology and are widely found in the general population. Most have no direct impact on health and simply represent natural variation among people. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors play a role. In some situations, though, a single well characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce risk related to the GNAL gene. In families with a disease-causing GNAL variant, some people develop dystonia and others do not, which suggests other genes and life factors may play a part, but these are not clearly defined.
Inheritance of GNAL variants
GNAL-related dystonia is usually inherited in an autosomal dominant pattern, which means one altered copy of the GNAL gene can be enough to raise the chance of developing the condition. If a parent carries a disease-causing GNAL variant, each child has a 50% chance of inheriting that variant, and it can be passed on by either the mother or the father. In practice, how GNAL variants are inherited is straightforward, but not everyone who inherits the variant will develop symptoms.
What does my GNAL result mean for my family?
For GNAL, a disease-causing result is usually linked to a dominant pattern, which means close relatives like parents, brothers, sisters, and children may also carry the same change. In families with a GNAL-related movement condition, each child of someone who carries the variant has a 1 in 2, or 50%, chance of inheriting it. Not everyone who inherits a GNAL variant will develop symptoms, so family history can look mixed.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a change in the GNAL gene, doctors use genetic testing for GNAL variants, usually on a blood sample or cheek swab. A lab reads the gene’s DNA sequence and compares it with the usual pattern to look for variants that may help explain symptoms such as dystonia or support family testing.
When should I consider getting a genetic test?
Genetic testing for the GNAL gene may be worth considering if you or several relatives have unexplained dystonia, especially adult-onset neck turning, head tremor, or abnormal postures that run in the family. A GNAL result can help confirm whether an inherited form of dystonia is present and may clarify family risk.
A genetic result is only one part of your health story
Genetic test results can provide valuable insight, but how much they reveal depends on the condition and the specific type of variant involved. Many other factors, including lifestyle, environment, age, and medical history, also influence how the body functions over time. For some conditions, especially those shaped by many genes, genetic information provides context rather than certainty and is most useful when considered alongside other parts of care. In other situations, a genetic result can give a clear answer. In areas like medication response, genetic results may also help place personal experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in genes can change how the body breaks down a drug, moves it through the bloodstream, or responds to it at its target. This helps explain why the same medication may work well for one person, seem less effective for another, or cause more side effects in someone else.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in genes affect the way people respond to medications. It focuses on relationships between genes and drugs to help explain why the same treatment can work differently from one person to another. For many medicines, genes influence either how strongly a drug works or how the body handles it. This information can support treatment decisions that are more informed and more individualized. More on this topic is available in the LearnHub.
Drugs influenced by the GNAL gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medicine choice or dosing. If you have new side effects, your treatment is not working as expected, or you have questions about any medicine or supplement, it is best to talk with your doctor or pharmacist.
History
The GNAL gene first drew scientific attention in the early 1990s, when researchers identified it while studying signaling proteins in the brain and smell system. Early work focused on where the gene was active rather than on its role in inherited disease. From these first observations, research expanded steadily. A major turning point came in 2013, when variants in the GNAL gene were linked to some families with inherited dystonia, a movement condition that can cause twisting movements or unusual postures. That finding placed the GNAL gene more clearly within medical genetics and helped explain certain cases that had previously remained unsolved. Since then, studies have refined which GNAL variants are disease causing and how they appear across different families.